NCCN Guidelines ® Insights: Breast Cancer, Version 4.2021

J Natl Compr Canc Netw. 2021 May 1;19(5):484-493. doi: 10.6004/jnccn.2021.0023.ABSTRACTThe NCCN Guidelines for Breast Cancer include up-to-date guidelines for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor, inflammatory breast cancer, male breast cancer, and breast cancer during pregnancy. These guidelines are developed by a multidisciplinary panel of representatives from NCCN Member Institutions with breast cancer-focused expertise in the fields of medical oncology, surgical oncology, radiation oncology, pathology, reconstructive surgery, and patient advocacy. These NCCN Guidelines Insights focus on the most recent updates to recommendations for adjuvant systemic therapy in patients with nonmetastatic, early-stage, hormone receptor-positive, HER2-negative breast cancer.PMID:34030128 | DOI:10.6004/jnccn.2021.0023

Source: Journal of the National Comprehensive Cancer Network : JNCCN - May 24, 2021 Category: Cancer & Oncology Authors: William J Gradishar Meena S Moran Jame Abraham Rebecca Aft Doreen Agnese Kimberly H Allison Sarah L Blair Harold J Burstein Chau Dang Anthony D Elias Sharon H Giordano Matthew P Goetz Lori J Goldstein Sara A Hurvitz Steven J Isakoff Rachel C Jankowitz Sar Source Type: research